Related Experiment Video
Updated: Jan 7, 2026

Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
Dementia Care Research and Psychosocial Factors
Leonardo Ryuiti Kimoto1,2, Júlia de Almeida Barreto1,2,3, João Vitor da Silva Viana1,2
1Cog-Aging Research Group, Belo Horizonte, Minas Gerais, Brazil.
Background:
It is predicted that the prevalence of Alzheimer's disease (AD) in low and middle income countries (LMIC) will rise more rapidly than in high-income countries. Pharmacotherapy for AD are associated with a variety of cardiovascular (CV) issues including heart block, sinus bradycardia and syncope. Regarding this fact, it is of utmost importance to evaluate CV health before starting therapy, with EKG being an important tool to evaluate heart blocks, bradycardia, rhythm disturbances and prolonged QTc. Recently multiple EKGs portable devices were released. They can potentially be used to help the decision making in AD therapy in a more accessible and faster way in remote outpatient settings in LMIC, where EKGs aren't as easily available.
Method:
To compare the accuracy of 2 portable EKG devices, using a 12-lead-EKG as baseline, one hundred participants followed in Cog-Aging cohort in Brazil were submitted to EKG evaluation. All were assessed by 12-lead-EKG, 95 of them by Kardiamobile 6L and 52 by Samsung Watch Active 2. Normality of distribution was assessed by Shapiro-Wilk test, accuracy of QTc interval was assessed by Pearson's correlation test, and HR and PRi accuracy was evaluated by Spearman's correlation test.
Result:
The patients presented a median age of 77, with 76% being women, 51% white, 46% presenting MCI, 34% presenting probable AD dementia (ADD) and 20% with no cognitive impairment. Comparisons between the 3 devices did not show statistical differences for QTc (p = 0,412) in ANOVA test and for PRi (p = 0.383), HR (p = 0,159) in Kruskal-Wallis test. Kardia L6 presented a stronger correlation with 12-lead-EKG for PRi(rho = 0.769) and QTc (r = 0,822) and Samsung's device presented a stronger correlation for HR(rho = 0.884) CONCLUSION: This is a preliminary study regarding the use of portable EKG devices to assess cardiovascular issues related to pharmacotherapy in AD. Considering its ease of use, accessibility and accuracy, portable EKG are a promising technology to make decision-making faster and more immediate in remote outpatient settings.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Psychological and Sociocultural Causes of Schizophrenia
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities